By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NanoViricides, Inc. 

135 Wood Street, Suite 205

West Haven  Connecticut  06516  U.S.A.
Phone: n/a Fax:


Company News
NanoViricides, Inc. (NNVC.PK) Reports Its Drug Candidates Significantly Reduced The Extent Of Shingles Virus Infection Of Human Skin 7/10/2017 6:58:56 AM
NanoViricides, Inc. (NNVC.PK)' Poster "Novel Nanoviricides Highly Effective Against Varicella Zoster Virus In Cell Culture" To Be Presented Today At The 2017 Annual Meeting Of American Society Of Virology 6/26/2017 10:18:38 AM
NanoViricides, Inc. (NNVC.PK) Reports Excellent Inhibitory Effects Of Its Topical Shingles Treatment Candidates Against VZV In Multiple Cell Culture Studies 6/7/2017 7:00:13 AM
NanoViricides, Inc. (NNVC.PK) Files Quarterly Report for Period Ending 2017-03-31 5/16/2017 11:10:24 AM
NanoViricides, Inc. (NNVC.PK) Files Quarterly Report For Period Ending 2016-12-31 2/16/2017 9:47:48 AM
NanoViricides, Inc. (NNVC.PK) Reports The Company's Director Dr. Boniuk Converted Series B Debenture To Equity Effectively Raising $5 Million In New Equity For The Company 2/13/2017 6:26:15 AM
NanoViricides, Inc. (NNVC.PK) Files Quarterly Report For Period Ending 2016-09-30 11/15/2016 10:44:03 AM
NanoViricides, Inc. (NNVC.PK) President Dr. Diwan Gave Invited Talks On Regulatory Aspects Of Nanomedicines 11/7/2016 11:52:00 AM
NanoViricides, Inc. (NNVC.PK) Signs Agreement With SUNY Upstate Medical Center For Testing Of Its Drug Candidates For The Treatment Of Shingles 10/31/2016 6:46:56 AM
NanoViricides, Inc. (NNVC.PK) Has Filed Annual Report, Says Company Has Sufficient Cash To Advance Into Clinical Trials 10/11/2016 9:23:08 AM